Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Processing

Read more breaking news


News in brief

Fareva opens aerosol plant as part of $40m drug and OTC business investment

By Gareth MacDonald+

Last updated on 08-Dec-2016 at 11:45 GMT2016-12-08T11:45:40Z


Fareva Group has set up an aerosol manufacturing facility at its site in Richmond, Virginia as part of a $40m (€37m) investment in its drug, OTC medicine and beauty care business.

The plant has capacity to make 100 million aerosols cans a year according to Fareva, which said it plans to hire 80 to 100 people. The next phase of the project will see the firm invest a further $20m to set up four additional manufacturing lines.

Fareva bought the Richmond site from Pfizer in 2011 . At present, it makes topical drugs, over the counter medicines - including the cough treatment Robitussin (guaifenesin) - and various consumer products for the North American market.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...